Zobrazeno 1 - 7
of 7
pro vyhledávání: '"CM Lustosa"'
Autor:
ACL Alves, MRA Gomes, AS Ramos, CM Lustosa, G Zamperlini, LL Quintino, VC Ginani, RV Gouveia, A Seber, OMWO Félix
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S991- (2024)
A major challenge for transplant centers is the graft acquisition when a compatible unrelated donor is chosen for the procedure. In addition to the complex logistics that involve several critical steps and the need of an experienced multidisciplinary
Externí odkaz:
https://doaj.org/article/1d0ca67dcc8c46aebbd845e7ea3f649f
Autor:
ASS Ibanez, CM Lustosa, CMMS Parrode, RV Gouveia, MGAD Matos, VC Ginani, LL Quintino, MF Cardoso, LDS Domingues, A Seber
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S1011- (2024)
Introduction: Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by variable levels of impairment in social behavior and communication that can be seen even in the first months of life. The diagnosis is usually best establi
Externí odkaz:
https://doaj.org/article/6c22bd3f32af4e93a1f0095995c74eb3
Autor:
ASS Ibanez, NC Villela, RCS Dias, VAR Colturato, CM Lustosa, CMMS Parrode, MDH Almeida, GR Quevedo, LF Lopes, A Seber
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S1015-S1016 (2024)
Introduction: Childhood cancer is the first cause of death from disease in children and the second cause of death in general. Children and adolescents have around an 80% chance of being cured with early diagnosis and treatment in specialized centers.
Externí odkaz:
https://doaj.org/article/c09841051ff04b7d8a7ce9b8c8379de4
Autor:
RV Gouveia, LL Quintino, CM Lustosa, ASS Ibanez, MGAD Matos, CMMSS Parrode, VADN Varjão, CNM Breviglieri, VC Ginani, A Seber
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S1038-S1039 (2024)
Introduction: HCT is the only curative option for patients with sickle cell anemia in our country. Unfortunately, few have an unaffected HLA-identical sibling donor. Haploidentical donors are a feasible and effective option. Objective: This study is
Externí odkaz:
https://doaj.org/article/efc3a565875542008c183eec867cf75f
Autor:
CM Lustosa, CMV Alferi, ASS Ibanez, CMM Parrode, LL Quintino, LDS Domingues, MGAD Matos, G Zamperlini, MF Cardoso, A Seber
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S521- (2023)
Introdução: O Transplante de Células-Tronco Hematopoiéticas (TCTH) é uma modalidade terapêutica que pode beneficiar muitos pacientes com diferentes doenças. No entanto, existem limitações que podem atrasar o tratamento ou impedir que a crian
Externí odkaz:
https://doaj.org/article/f1d751c541564edba40971d5b69b919c
Autor:
ASS Ibanez, CM Lustosa, CMM Parrode, LL Quintino, LDS Domingues, MGAD Matos, G Zamperlini, RV Gouveia, VC Ginani, A Seber
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S522- (2023)
Introduction: Hematopoietic Stem Cell Transplantation (HSCT) is a complex procedure in which patients and their families are faced with several challenges. The patient/family need constant support and clarification of the entire HSCT process. The con
Externí odkaz:
https://doaj.org/article/9e0c588cf62a4fb0963edd418bcd141e
Autor:
CMMSS Parrode, AS Ibanez, CM Lustosa, V Varjão, LL Quintino, LDS Domingues, MGAD Matos, G Zamperlini, RV Gouveia, A Seber
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S521-S522 (2023)
Introduction: Despite the progress in Haploidentical Stem Cell Transplantation (HSCT), many patients do not have a suitable healthy family donor. Transplants from matched unrelated donors would be ideal, but they are not available to most patients. O
Externí odkaz:
https://doaj.org/article/412fae82ce1244a19ca78465dfcc1ee7